|
?:authorAffiliation
|
-
[\'Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.\', \'Department of Medicine, University of Toronto, Toronto, ON, Canada.\', \'Department of Haematology, University College London Hospital, London, United Kingdom.\', \'Department of Oncology, University of Oxford, Oxford, United Kingdom.\', \'Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.\', \'Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy.\', \'Ca\' Granda Ospedale Maggiore Policlinico, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.\', \'Department of Hematology, Ramón y Cajal University Hospital, Madrid, Spain.\', \'Department of Internal Medicine, Besançon University Hospital, Besançon, France.\', \'Centre for Hemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.\', \'Beth Israel Deaconess Medical Center, Boston, MA.\', \'Department of Hematology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.\', \'Strategic Research Program on CLL, Università Vita Salute and IRCCS Ospedale San Raffaele, Milan, Italy.\', \'HCT Unit, Hematology Department, G. Papanicolaou Hospital, Thessaloniki, Greece.\', \'Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.\', \'Department of Oncology, Montefiore Medical Center, Bronx, NY.\', \'Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and.\', \'Division of Hematology/Oncology, St. Michael\'s Hospital, Toronto, ON, Canada.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}